This inventor holds 6 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Chemocentryx, Inc.. Active years: 2007-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Royersford, PA (US) (2010)
- San Mateo, CA (US) (2007 - 2011)
Company Filing History:
Years Active: 2007-2011
Title: The Innovative Contributions of Jennifer M. Burns
Introduction
Jennifer M. Burns is an accomplished inventor based in San Mateo, California, who has significantly contributed to the field of biomedical research. With a robust portfolio of six patents, her work focuses on the detection and treatment of diseases linked to chemokine receptors, specifically CCX-CKR2. Her innovative approach has the potential to transform therapeutic interventions in oncology.
Latest Patents
Jennifer's latest patents include groundbreaking compositions and methodologies designed for detecting and treating diseases associated with chemokine receptors. One notable patent describes the ligands of CCX-CKR2 and explores the biological role of this receptor in cancer. Additionally, another patent details the development of antibodies that specifically bind to CCX-CKR2, providing advanced solutions for medical diagnosis and treatment.
Career Highlights
Jennifer M. Burns is currently employed at Chemocentryx, Inc., a prominent biotechnology company dedicated to bringing innovative therapies to patients. Her expertise and dedication to research are reflected in her essential contributions to the company's pipeline of drugs aimed at treating serious diseases.
Collaborations
Throughout her career, Jennifer has collaborated with esteemed colleagues, including Thomas J. Schall and Maureen Howard. These partnerships have further enhanced her research and have been instrumental in driving forward the company's objectives in understanding and treating complex medical conditions.
Conclusion
Jennifer M. Burns exemplifies the spirit of innovation and dedication in the field of biomedical research. Through her patents and collaborative efforts, she continues to make a significant impact on health care solutions, particularly in understanding the role of chemokine receptors in cancer treatment. Her contributions reflect the vital intersection of science and technology in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile